Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure the (a) supply and (b) availability of the drug Methotrexate after the UK leaves the EU.

The United Kingdom’s position on medicines regulation remains clear. We are working to retain a close working partnership with the European Union to ensure that medicines remain available to UK patients in a safe and timely manner. We have been clear that this involves us making sure our regulators continue to work together, as they do with regulators internationally.